Discontinued — last reported Q4 '21
Johnson & Johnson Stock Issuance Proceeds increased by 1090.7% to $1.27B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 200.5%, from $424.00M to $1.27B.
While it provides cash, frequent issuance can lead to share dilution unless offset by a robust share repurchase program.
Cash received from the sale of common stock, which in large tech companies is primarily driven by employee participation...
High-growth tech companies often have significant inflows here due to stock-based compensation structures.
cf_proceeds_from_stock_issuance| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $236.00M | $321.00M | -$11.00M | $195.00M | $95.00M | $424.00M | $124.00M | $450.00M | $107.00M | $1.27B |
| QoQ Change | — | +36.0% | -103.4% | >999% | -51.3% | +346.3% | -70.8% | +262.9% | -76.2% | >999% |
| YoY Change | — | +36.0% | -103.4% | — | +963.6% | — | — | +130.8% | +12.6% | +200.5% |
We use cookies for analytics. See our Privacy and Cookie Policy.